**Chapter 6**

*Antisense Therapy*

Cancer Research. 2016;**35**(1):35-57. DOI:

10.1186/s13046-016-0334-y

[58] Gao LY, Liu XY, Chen CJ, Wang JC, Feng Q, Yu MZ, et al. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery. Biomaterials. 2014;**35**(6):2066-2078. DOI: 10.1016/j.

biomaterials.2013.11.046

biomaterials.2014.12.028

10.1016/j.ajps.2014.08.011

[60] Xu C, Wang J. Delivery systems for siRNA drug development in cancer therapy. Asian Journal of Pharmaceutics. 2015;**10**(1):1-12. DOI:

[59] Zhao X, Li F, Li Y, Wang H, Ren H, Chen J, et al. Co-delivery of HIF1alpha siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Biomaterials. 2015;**46**:13-25. DOI: org/10.1016/j.

**92**
